相似文献
1
Antiretroviral therapy in Africa.
BMJ. 2004 Jan 31;328(7434):280-2. doi: 10.1136/bmj.328.7434.280.
2
Unexpected resistance in an African immigrant: lessons for the unwary.
Sex Transm Infect. 2004 Apr;80(2):155. doi: 10.1136/sti.2003.007542.
3
Resistance to antiretroviral drugs: a threat to the prevention and treatment of pediatric HIV infection.
J Infect Dis. 2007 May 15;195(10):1393-5. doi: 10.1086/513880. Epub 2007 Apr 5.
4
[Antiretroviral therapy of HIV infection. German-Austrian guidelines (position in September 2008)].
Dtsch Med Wochenschr. 2009 Jan;134 Suppl 1:S4-15. doi: 10.1055/s-0028-1123965. Epub 2009 Jan 26.
5
Antiretroviral therapy adherence in children: outcomes from Africa.
AIDS. 2008 Apr 23;22(7):906-7. doi: 10.1097/QAD.0b013e3282f706ba.
6
Continued correspondence 'Will ART rollout in Africa drive an epidemic of drug-resistant HIV?'.
AIDS. 2007 Jan 11;21(2):258-9; author reply 259-60. doi: 10.1097/QAD.0b013e32801121fb.
7
Predicting and monitoring antiretroviral adherence.
LDI Issue Brief. 2007 Nov-Dec;13(2):1-4.
8
Directly observed therapy for HIV/tuberculosis co-infection.
Lancet Infect Dis. 2004 Mar;4(3):137-8. doi: 10.1016/S1473-3099(04)00936-3.
9
(ARV-) Free State? The moratorium's threat to patients' adherence and the development of drug-resistant HIV.
S Afr Med J. 2009 Jun;99(6):412, 414.
10
[AIDS treatment in Africa: the risk of antiretroviral resistance].
Ned Tijdschr Geneeskd. 2007 Dec 1;151(48):2666-71.
引用本文的文献
1
Antiviral and antiretroviral drug shortages amidst COVID-19: How Africa is struggling.
Innov Pharm. 2021 Sep 22;12(4). doi: 10.24926/iip.v12i4.4328. eCollection 2021.
2
"If She is Drunk, I Don't Want Her to Take it": Partner Beliefs and Influence on Use of Alcohol and Antiretroviral Therapy in South African Couples.
AIDS Behav. 2017 Jul;21(7):1885-1891. doi: 10.1007/s10461-017-1697-6.
3
Convergence of mortality rates among patients on antiretroviral therapy in South Africa and North America.
PLoS Med. 2014 Sep 9;11(9):e1001719. doi: 10.1371/journal.pmed.1001719. eCollection 2014 Sep.
4
AIDS and drug rationing.
J Med Ethics Hist Med. 2010 Mar 16;3:1. Print 2010.
5
Factors influencing adherence to antiretroviral treatment in Nepal: a mixed-methods study.
PLoS One. 2012;7(5):e35547. doi: 10.1371/journal.pone.0035547. Epub 2012 May 1.
6
Primary drug resistance in South Africa: data from 10 years of surveys.
AIDS Res Hum Retroviruses. 2012 Jun;28(6):558-65. doi: 10.1089/aid.2011.0284. Epub 2012 Mar 12.
7
Predictors of linkage to care following community-based HIV counseling and testing in rural Kenya.
AIDS Behav. 2012 Jul;16(5):1295-307. doi: 10.1007/s10461-011-0065-1.
8
Trends in the clinical characteristics of HIV-infected patients initiating antiretroviral therapy in Kenya, Uganda and Tanzania between 2002 and 2009.
J Int AIDS Soc. 2011 Sep 28;14:46. doi: 10.1186/1758-2652-14-46.
9
HIV treatment adherence, drug resistance, virologic failure: evolving concepts.
Infect Disord Drug Targets. 2011 Apr;11(2):167-74. doi: 10.2174/187152611795589663.
10
Barriers to the care of HIV-infected children in rural Zambia: a cross-sectional analysis.
BMC Infect Dis. 2009 Oct 16;9:169. doi: 10.1186/1471-2334-9-169.
本文引用的文献
1
High levels of adherence do not prevent accumulation of HIV drug resistance mutations.
AIDS. 2003 Sep 5;17(13):1925-32. doi: 10.1097/00002030-200309050-00011.
2
Adherence is not a barrier to successful antiretroviral therapy in South Africa.
AIDS. 2003 Jun 13;17(9):1369-75. doi: 10.1097/00002030-200306130-00011.
3
Fitness of drug resistant HIV-1: methodology and clinical implications.
Drug Resist Updat. 2002 Dec;5(6):224-33. doi: 10.1016/s1368-7646(02)00123-1.
4
Antiretroviral-drug resistance among patients recently infected with HIV.
N Engl J Med. 2002 Aug 8;347(6):385-94. doi: 10.1056/NEJMoa013552.
5
The Senegalese government's highly active antiretroviral therapy initiative: an 18-month follow-up study.
AIDS. 2002 Jul 5;16(10):1363-70. doi: 10.1097/00002030-200207050-00008.
6
Managing medication compliance of tuberculosis patients in Haiti with medication monitors.
Int J Tuberc Lung Dis. 2002 Apr;6(4):313-9.
7
Factors affecting patient compliance with anti-tuberculosis chemotherapy using the directly observed treatment, short-course strategy (DOTS).
Int J Tuberc Lung Dis. 2002 Apr;6(4):307-12.
8
Extent of cross-resistance between agents used to treat human immunodeficiency virus type 1 infection in clinically derived isolates.
Antimicrob Agents Chemother. 2002 Mar;46(3):909-12. doi: 10.1128/AAC.46.3.909-912.2002.
9
Improving adherence to malaria treatment for children: the use of pre-packed chloroquine tablets vs. chloroquine syrup.
Trop Med Int Health. 2001 Jul;6(7):496-504. doi: 10.1046/j.1365-3156.2001.00740.x.
10
The cumulative occurrence of resistance mutations in the HIV-1 protease gene is associated with failure of salvage therapy with ritonavir and saquinavir in protease inhibitor-experienced patients.
Antiviral Res. 2000 Sep;47(3):179-88. doi: 10.1016/s0166-3542(00)00110-8.
Zotero 插件